Antimalarial stocking decisions among medicine retailers in Ghana: implications for quality management and control of malaria

Author:

Osman Adams,Amoako Johnson Fiifi,Mariwah Simon,Amoako-Sakyi Daniel,Asiedu Owusu Samuel,Ekor Martins,Hamill HeatherORCID,Hampshire Kate

Abstract

Global health efforts such as malarial control require efficient pharmaceutical supply chains to ensure effective delivery of quality-assured medicines to those who need them. However, very little is currently known about decision-making processes within antimalarial supply chains and potential vulnerabilities to substandard and falsified medicines. Addressing this gap, we report on a study that investigated decision-making around the stocking of antimalarial products among private-sector medicine retailers in Ghana. Licensed retail pharmacies and over-the-counter (OTC) medicine retail outlets were sampled across six regions of Ghana using a two-stage stratified sampling procedure, with antimalarial medicines categorised as ‘expensive,’ ‘mid-range,’ and ‘cheaper,’ relative to other products in the shop. Retailers were asked about their motivations for choosing to stock particular products over others. The reasons were grouped into three categories: financial, reputation/experience and professional recommendation. Reputation/experience (76%, 95% CI 72.0% to 80.7%) were the drivers of antimalarial stocking decisions, followed by financial reasons (53.2%, 95% CI 48.1% to 58.3%) and recommendation by certified health professionals (24.7%, 95% CI 20.3% to 29.1%). Financial considerations were particularly influential in stocking decisions of cheaper medicines. Moreover, pharmacies and OTCs without a qualified pharmacist were significantly more likely to indicate financial reasons as a motivation for stocking decisions. No significant differences in stocking decisions were found by geographical location (zone and urban/rural) or outlet (pharmacy/OTC). These findings have implications for the management of antimalarial quality across supply chains in Ghana, with potentially important consequences for malaria control, particularly in lower-income areas where people rely on low-cost medication.

Funder

Medical Research Council

Publisher

BMJ

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference42 articles.

1. Study on the public health & socioeconomic impact of SF medical products. Geneva World Health Organisation; 2017.

2. WHO . WHO global surveillance and monitoring system for substandard and falsified medical products. Geneva: World Health Organization, 2017b. Available: https://apps.who.int/iris/handle/10665/326708

3. Ozawa S , Evans DR , Bessias S , et al . Prevalence and estimated economic burden of substandard and falsified medicines in low- and middle-income countries: a systematic review and meta-analysis. JAMA Netw Open 2018;1:e181662. doi:10.1001/jamanetworkopen.2018.1662

4. A new handheld device for the detection of falsified medicines: demonstration on falsified artemisinin-based therapies from the field;Wilson;Am J Trop Med Hyg,2017

5. Quality of artemisinin-based combination therapy for malaria found in Ghanaian markets and public health implications of their use;Tivura;BMC Pharmacol Toxicol,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3